Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

With the reelection of Donald Trump, we could be looking at further erosion of any semblance of oversight of supplements on ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

It’s hard to know exactly what change in Washington will mean for the health care industry starting next year. But we have ...

sided with industry when it issued its Bioengineered Food labeling regime in 2018. Trump’s USDA also relaxed school nutrition ...

Trump ally Robert F. Kennedy Jr. has expressed skepticism about vaccines and vowed to restructure federal health agencies.

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

A physician is raising the alarm about what he calls 'concern' in the health care industry about RFK Jr.'s potential role in ...

“All extremes are plausible,” Bates said. The Food and Drug Administration was handed oversight of the industry by a Democratic-controlled Congress in June 2009 — early in the Obama administration — ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...